FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall - FDA Press Releases

FDA provides update on ongoing investigation into ARB drugs; new losartan recall announced

from Food and Drug Administration--Press Releases https://ift.tt/2Tp8vbE
via IFTTT